Browse By

Tag Archives: APHA

Aphria Inc. Announces Closing of $100 Million Strategic Investment from Institutional Investor

LEAMINGTON, ON, Jan. 31, 2020 /PRNewswire/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA) today announced that it closed its previously announced strategic investment from an institutional investor (the “Significant Investor”) for aggregate gross proceeds to the Company of C$100,000,001 (the “Offering”). Pursuant to the Offering, the Significant Investor has agreed to

Aphria Inc. Enters Into Agreement to Receive $100 Million Strategic Investment from Institutional Investor

Further Strengthening Aphria’s Cash Balance Pro Forma to Nearly $600 million1Company Also Provides Corporate Updates LEAMINGTON, ON, Jan. 24, 2020 /PRNewswire/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA) today announced that it has entered into an agreement to accept a strategic investment from an institutional investor (the “Significant

Aphria Inc. Receives EU GMP Certification for Aphria One Facility

Second EU GMP certification bolsters Company’s international export capabilities LEAMINGTON, ON, Jan. 22, 2020 /PRNewswire/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA) today announced that it has received its European Union Good Manufacturing Practices (“EU GMP“) certification as an active substance manufacturer in accordance with Art.111

Aphria Inc. Announces Third Consecutive Quarter of Positive Adjusted EBITDA and a 46% Increase in Adult-Use Cannabis Revenue From Prior Quarter

Adjusted EBITDA from Cannabis Operations of $3.4 Million Increased 155% from Prior QuarterStrengthened Balance Sheet and Cash PositionReceived EU GMP compliance confirmation for ARA-Avanti Rx AnalyticsUpdates Fiscal Year 2020 Outlook LEAMINGTON, ON, Jan. 14, 2020 /PRNewswire/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA) today reported its results for

Aphria Inc. to Participate in the 2020 ICR Conference

LEAMINGTON, ON, Jan. 7, 2020 /CNW/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA), a leading global cannabis company, today announced its participation in the 2020 ICR Conference on Tuesday, January 14, 2020 in Orlando, FL. In addition to pre-scheduled one-on-one meetings, Irwin D. Simon and Carl Merton will participate in a fireside

Aphria Inc. to Announce Second Quarter Fiscal 2020 Financial Results on January 14, 2020

LEAMINGTON, ON, Dec. 30, 2019 /CNW/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA), a leading global cannabis company, will release financial results for its second quarter and six months ended November 30, 2019 on January 14, 2020 before market open.   Aphria executives will host a conference call to discuss